# Dietary Treatment Strategies and Metabolic Control in Glycogen Storage Disease Type I

> **NCT06852612** · NA · RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 20 (estimated)

## Conditions studied

- Glycogen Storage Disease Type I

## Interventions

- **DIETARY_SUPPLEMENT:** Fructose
- **DIETARY_SUPPLEMENT:** Fructose and galactose

## Key facts

- **NCT ID:** NCT06852612
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-24
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-05-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06852612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06852612, "Dietary Treatment Strategies and Metabolic Control in Glycogen Storage Disease Type I". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT06852612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*